New model-of-care improves Type 2 Diabetes outcomes in Indigenous Australians

An innovative model-of-care for Indigenous Australians in remote communities with Type 2 Diabetes has shown to significantly improve sugar management. Diabetes affects Indigenous Australians at more than three to four times the rate of non-Indigenous Australians.

A study known as the Lower Sugar Study found that weekly Exenatide-LAR combined with a weekly nurse review demonstrated greater improvements in sugar levels, highlighting its potential for use in remote communities.

A trial of this model found that it was associated with greater clinic attendance and willingness to receive care. It is expected these findings will contribute to improved Indigenous health outcomes.

Read more